Petros Pharmaceuticals annual revenue
2020
2021
2022
2023
2024
2025
Petros Pharmaceuticals Revenue Growth & History (PTPI)
Petros Pharmaceuticals reported $0 in revenue for fiscal 2025, a decrease of 100.00% from the previous fiscal year.
View full Petros Pharmaceuticals company overviewPetros Pharmaceuticals annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0 | −$5.1M | −100.00% |
| 2024 | 2024-12-31 | $5.1M | −$710,345 | −12.20% |
| 2023 | 2023-12-31 | $5.8M | −$169,666 | −2.83% |
| 2022 | 2022-12-31 | $6.0M | −$1.8M | −23.29% |
| 2021 | 2021-12-31 | $7.8M | −$1.7M | −18.29% |
| 2020 | 2020-12-31 | $9.6M | — | — |
Petros Pharmaceuticals quarterly revenue
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | $0 | — |
| Q1 2026 | 2026-03-31 | $0 | $0 | — |
| Q4 2025 | 2025-12-31 | $0 | −$725,400 | −100.00% |
| Q3 2025 | 2025-09-30 | $0 | −$1.6M | −100.00% |
| Q2 2025 | 2025-06-30 | $0 | −$1.4M | −100.00% |
| Q1 2025 | 2025-03-31 | $0 | −$1.4M | −100.00% |
| Q4 2024 | 2024-12-31 | $725,400 | $1.1M | +299.15% |
| Q3 2024 | 2024-09-30 | $1.6M | −$98,291 | −5.87% |
| Q2 2024 | 2024-06-30 | $1.4M | −$572,540 | −28.71% |
| Q1 2024 | 2024-03-31 | $1.4M | −$1.1M | −44.84% |
| Q4 2023 | 2023-12-31 | −$364,252 | −$1.2M | −145.64% |
| Q3 2023 | 2023-09-30 | $1.7M | $3.1M | +214.88% |
| Q2 2023 | 2023-06-30 | $2.0M | −$2.2M | −52.37% |
| Q1 2023 | 2023-03-31 | $2.5M | $52,803 | +2.14% |
| Q4 2022 | 2022-12-31 | $798,101 | $1.7M | +192.04% |
| Q3 2022 | 2022-09-30 | −$1.5M | −$3.6M | −167.95% |
| Q2 2022 | 2022-06-30 | $4.2M | $1.7M | +70.35% |
| Q1 2022 | 2022-03-31 | $2.5M | −$1.6M | −39.51% |
| Q4 2021 | 2021-12-31 | −$867,160 | −$3.8M | −129.60% |
| Q3 2021 | 2021-09-30 | $2.1M | −$1.3M | −38.08% |
| Q2 2021 | 2021-06-30 | $2.5M | $1.1M | +78.92% |
| Q1 2021 | 2021-03-31 | $4.1M | $2.3M | +127.44% |
| Q4 2020 | 2020-12-31 | $2.9M | — | — |
| Q3 2020 | 2020-09-30 | $3.5M | — | — |
| Q2 2020 | 2020-06-30 | $1.4M | — | — |
| Q1 2020 | 2020-03-31 | $1.8M | — | — |
Petros Pharmaceuticals revenue growth trends
Petros Pharmaceuticals's latest reported quarter, Q2 2026, generated $0 in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Petros Pharmaceuticals source filings ↗